Home / Inspections / 614298

FDA Inspection 614298 — Morton Grove Pharmaceuticals, Inc.

Morton Grove Pharmaceuticals, Inc. — FEI 1420913

The FDA completed an inspection of Morton Grove Pharmaceuticals, Inc. on September 17, 2009 in Morton Grove, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 17, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Morton Grove, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 964577 (OAI Fri Feb 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 870006 (VAI Wed Mar 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 702633 (VAI Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 651880 (VAI Wed Mar 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 568902 (VAI Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources